|Day Low/High||26.34 / 26.80|
|52 Wk Low/High||16.56 / 29.44|
Patents Covering VIMOVO Infringed by Proposed Generics Developed by Dr. Reddy's Laboratories, Mylan, and Lupin
Data Show Benefit of KRYSTEXXA Regardless of Clinically Apparent Tophi
Study Findings Underscore Burden of Gout on Patients and Healthcare System and Need for Improved Disease Management
Here's how to potentially rake in some fat profits off a number of hot breakout setups.
The most recent short interest data has been released for the 05/15/2017 settlement date, which shows a 1,518,745 share decrease in total short interest for Horizon Pharma plc , to 12,055,991, a decrease of 11.19% since 04/28/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.
Patent Covering PENNSAID® 2% Infringed by a Proposed Generic Developed by Actavis Laboratories UT, Inc.
The most recent short interest data has been released for the 04/28/2017 settlement date, which shows a 1,239,832 share increase in total short interest for Horizon Pharma plc , to 13,574,736, an increase of 10.05% since 04/13/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.
Volatility sank to its lowest level since 1993 to begin the new week as indexes held close to their flatlines.
Volatility sinks to its lowest level since Bill Clinton held the Oval Office, making for a listless and lethargic beginning to the new week.
Stocks are slightly lower again Monday afternoon as volatility hits its lowest level since the early 1990s.
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
Stocks creep lower on Monday after centrist Emmanuel Macron wins the French election, a result that was widely expected.
Horizon Pharma, OncoMed Pharmaceuticals and Inovio Pharmaceuticals were among the biotech stock movers in early trading on Monday.
Stock futures dip on Monday after centrist Emmanuel Macron claims victory in the French election, a result widely expected.
Will Represent the Sixteenth U.S. Patent Listed in the Orange Book for VIMOVO
Jim Cramer is bearish on Advanced Micro Devices and Boeing; prefers EMCOR Group to Chicago Bridge and Iron.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.